Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers
On this episode of Stock Movers: - Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares…
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
